InsiderTrades

Form 4 for XYL Xylem Inc.

Accepted 2022-06-29 00:00:00 ET · period of report 2022-06-27 · accession 0001209191-22-039773 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-06-29 2022-06-27 XYL Yarkadas Hayati SVP M - OptEx $63.55 +5,898 15.5K +62% +$374.8K
D 2022-06-29 2022-06-27 XYL Yarkadas Hayati SVP S - Sale+OE $80.06 -5,898 9,556 -38% -$472.2K
D 2022-06-29 2022-06-27 XYL Yarkadas Hayati SVP M - OptEx $0.00 -5,898 6,076 -49% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-27 M A 5,898 $63.55 15,454 D — — (F1) The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022.
2 Common Common Stock 2022-06-27 S D 5,898 $80.06 9,556 D — — (F1) The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022. (F2) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were sold at a range of prices from $80.00 to $80.31. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
3 Derivative Employee Stock Option (Right to Buy) 2022-06-27 M D 5,898 $0.00 6,076 D $63.55 · — to 2030-02-27 5,898 Common Stock (F3) The May 7, 2020 option grant vests in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023.